Rhelixa

About:

Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.

Twitter/X: rhelixainc

Top Investors: Global Brain Corporation, Mitsubishi Corporation, Japan Finance Corporation, Joyo Bank, Leave a Nest

Description:

Rhelixa is a leader in epigenome analysis.We analyze genomes, epigenomes, and transcriptomes using our proprietary technologies to dramatically improve the efficiency and accuracy of R & D.

Total Funding Amount:

740M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2015-02-01

Contact Email:

customer-service(AT)rhelixa.com

Founders:

Ryu Nakagi

Number of Employees:

51-100

Last Funding Date:

2024-08-22

IPO Status:

Private

Industries: